Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Journal of Neuropathology and Experimental Neurology|May 17, 2005
Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosisSelina Davies, Tim Nicholson, Matilde Laura, et al.The Lancet. Gastroenterology & Hepatology|December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyZhigang Liu, Kaixing Le, Xin Zhou, et al.Journal of Neuroinflammation|February 10, 2012
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)Nathali Kaushansky, Daniel M Altmann, Chella S David, et al.Gut|July 28, 2022
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemicNicholas A Kennedy, Malik Janjua, Neil Chanchlani, et al.Gut|April 12, 2019
Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trialEdward S Chambers, Claire S Byrne, Douglas J Morrison, et al.American Journal of Respiratory and Critical Care Medicine|June 19, 2007
Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosisLee Faulkner, Daniel M Altmann, Stephan Ellmerich, et al.Journal of Neuropathology and Experimental Neurology|November 7, 2006
The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognitionJeremy D Isaacs, Rebecca J Ingram, John Collinge, et al.Ebiomedicine|October 1, 2022
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infectionGabriella Captur, James C Moon, Constantin-Cristian Topriceanu, et al.The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.Science (New York, N.Y.)|December 2, 2021
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variantsCatherine J Reynolds, Joseph M Gibbons, Corinna Pade, et al.Pageof 13